NanoSphere Health Sciences, LLC

12/19/2019

Delta 9 Receives Extract Sales Authorization from Health Canada

https://bit.ly/38U8MIz

12/19/2019

NanoSphere Provides Update on United States Operations!

http://www.globenewswire.com/news-release/2019/12/09/1957931/0/en/NanoSphere-Provides-Update-on-United-States-Operations.html

11/05/2019

https://www.globenewswire.com/news-release/2019/11/04/1940311/0/en/NanoSphere-Provides-Update-on-Canadian-Operations.html

Vancouver, Nov. 04, 2019 (GLOBE NEWSWIRE) -- NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“Nanosphere” or “the Company”) wishes to provide an update regarding its operations in Canada, along with its Canadian partner, Delta 9 Cannabis Inc, (TSX:DN) (“Delta 9”).

05/02/2019

NanoSphere Health is pleased to announce that it has signed an MOU to form a strategic partnership with Stat Shield Technology. Stat will act as an exclusive agent to bring our patented technology to the Department of Defense and other agencies. For more details, please click here: https://bit.ly/2J0ivDF. $NSHS

The agreement will bring the patented NanoSphere Delivery System™ to the Department of Defense and other agencies

04/30/2019

Learn more: https://bit.ly/2GJ6iiY $NSHS.CN

04/24/2019

NanoSphere Health is pleased to announce we have received a patent allowance for the nanoparticle encapsulation of NSAIDs (non-steroidal anti-inflammatory drugs, such as ibuprofen, aspirin, naproxen, etc). Utilizing our patented delivery system, we look forward to making a safe and precise alternative for NSAID delivery. For more details, click here: https://bit.ly/2PrarvP. $NSHS

04/10/2019

"Consumers aren’t going to want to be waiting up to an hour or more to experience the effect of the product,” NanoSphere is featured in this article talking about our technology’s rapid onset. For the full article, click here: https://bit.ly/2ImzIpE. $NSHS

Canadians could have low-dose, individually packaged cannabis infused food and drinks by summer.

02/21/2019

NanoSphere Health is pleased to announce that it has closed its second and final tranche of its non-brokered private placement. For the full details, please click here: https://bit.ly/2TaQWvR $NSHS

02/20/2019

NanoSphere is pleased to announce the signing of the definitive licensing agreement with Cascade Pure to bring Evolve Formulas to the Oregon market. For more details, please click here:https://bit.ly/2SOSkVq
$NSHS

02/12/2019

NanoSphere is pleased to announce we have concluded a private placement of $2,000,000 CAD. Proceeds will be used to expand our award-winning Evolve Formulas' cannabis products into new markets in the US, Canada and Mexico, and to open new markets in Europe, Latin America, and Australasia. For the full details, please click here: https://bit.ly/2N9wMNz

01/24/2019

NanoSphere is pleased to announce our partnership with Delta 9 Cannabis Inc. We couldn't be more excited to bring our patented delivery technology to the Canadian market. For more details, please click here: https://bit.ly/2sK7XOH $NSHS

01/10/2019

NanoSphere is pleased to announce our partnership with Gofire to debut DoseCode-Enabled Evolve Formulas products in Colorado. We are excited to join forces with Gofire in educating patients on our products and dosing for maximum therapeutic benefit. For the full details, please click here: https://bit.ly/2RkNajw